Optimal prostate-specific antigen cutoff linked to improved prostate cancer survival

https://www.news-medical.net/news/20260810/Optimal-prostate-specific-antigen-cutoff-linked-to-improved-prostate-cancer-survival.aspx After treatment for metastatic prostate cancer, a drop in prostate-specific antigen (PSA) levels in the blood is an indicator that the treatment is working. A recent real-world study indicates that reaching a PSA level below 0.2 ng/mL is an indicator of improved patient survival. The study is published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.